Journal of Computer-Aided Molecular Design

, Volume 21, Issue 4, pp 145–153

3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach

Authors

    • Department of ChemistryCapital Normal University
  • Liying An
    • Department of ChemistryCapital Normal University
  • Wenxiang Hu
    • Department of ChemistryCapital Normal University
  • Yuhong Xiang
    • Department of ChemistryCapital Normal University
Original Paper

DOI: 10.1007/s10822-006-9090-y

Cite this article as:
Zhang, Z., An, L., Hu, W. et al. J Comput Aided Mol Des (2007) 21: 145. doi:10.1007/s10822-006-9090-y

Abstract

The three-dimensional quantitative structure–activity relationship (3D-QSAR) has been studied on 90 hallucinogenic phenylalkylamines by the comparative molecular field analysis (CoMFA). Two conformations were compared during the modeling. Conformation I referred to the amino group close to ring position 6 and conformation II related to the amino group trans to the phenyl ring. Satisfactory results were obtained by using both conformations. There were still differences between the two models. The model based on conformation I got better statistical results than the one about conformation II. And this may suggest that conformation I be preponderant when the hallucinogenic phenylalkylamines interact with the receptor. To further confirm the predictive capability of the CoMFA model, 18 compounds with conformation I were randomly selected as a test set and the remaining ones as training set. The best CoMFA model based on the training set had a cross-validation coefficient q2 of 0.549 at five components and non cross-validation coefficient R2 of 0.835, the standard error of estimation was 0.219. The model showed good predictive ability in the external test with a coefficient Rpre2 of 0.611. The CoMFA coefficient contour maps suggested that both steric and electrostatic interactions play an important role. The contributions from the steric and electrostatic fields were 0.450 and 0.550, respectively.

Keywords

3D-QSARAmphetaminesCoMFAHallucinogenPhenylethylamines

Copyright information

© Springer Science+Business Media, LLC 2006